D-0002-2026 Class II Ongoing

Recalled by Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

FDA drug recall D-0002-2026 was initiated by Zydus Pharmaceuticals (USA) Inc on Sep 24, 2025 and is designated Class II. Reason for recall: Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity The recall status is ongoing. Affected quantity: 600 30-count bottles.

Recall details

Product Type
Drugs
Report Date
Oct 8, 2025
Initiation Date
Sep 24, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
600 30-count bottles

Product description

Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.

Reason for recall

Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot#: E409309, Exp 12/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0002-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0002-2026. Report a data issue: hello@regdatalab.com.